ArticleNature communications2026

Disrupting fumarylacetoacetate hydrolase by stratified nanoplatforms orchestrates metabolic-immune reprogramming and prevents post-ablation HCC relapse.

Zhiwen Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.